Would you like to find out more about ASA’s studies and research?
Fill out the form, ASA’s Research Division is at your disposal.
This edition of Energy for Health offers four articles that delve into the use of ASA technologies in human and veterinary medicine. The first article examines the photothermal effects induced by laser, focusing on the interaction between light and biological tissues and the importance of these mechanisms for the safety and efficacy of laser therapies. The second showcases a clinical case that highlights the efficacy of MLS® Laser Therapy in managing peripheral neuropathic pain in a diabetic patient, with significant results in pain reduction and improved quality of life. The third article describes the use of MLS® Laser Therapy in treating a chronic venous ulcer, underlining an acceleration of the healing process and an effective reduction of pain. Finally, the last article focuses on applying pulsed electromagnetic fields (PEMF) in the treatment of multiple traumas in a dog, focusing on its value in neurological and motor recovery.
These contributions provide new scientific evidence on the efficacy of laser therapy and magnetotherapy, outlining innovative perspectives for the treatment of complex disorders in humans and animals.
Laser and photothermia: therapeutic effects and clinical safety
Management of peripheral neuropathic pain in diabetic patients with MLS® MiS Laser
Laser therapy in chronic venous ulcers: a clinical case
Veterinary rehabilitation: PEMF in the treatment of multiple traumas
In this new issue, the "Energy for Health" journal is pleased to present four papers that delve into the therapeutic applications of ASA technologies in the field of human and animal health. The first paper presents the results of a randomized study involving 76 patients that evaluates the effectiveness of MLS® Laser Therapy, compared to microwave diathermy and interferential current therapy, in managing glenohumeral peritendinitis. The second paper compares the effectiveness of Hilterapia® to that of shock wave therapy in the treatment of non-calcific rotator cuff tendinopathies. The third paper reports three interesting case reports on the application of MLS® therapy for promoting and improving the healing.of foot ulcers in diabetic patients. Finally, the fourth paper, belonging to the veterinary section, is focused on the use of pulsed electromagnetic fields to treat osteoarthritis in dogs, with the goal to improve joint mobility and reduce pain. These papers contribute to give clinical evidence of the therapeutic effects induced by ASA devices and they open new perspectives for the well-being of both human and animal patients.
Periarthritis scapulohumeralis: a randomised study with MLS® Laser Therapy
Rotator cuff tendinopathy: Hilterapia® versus Shockwaves
Diabetic foot ulcers: 3 case reports with MLS®
Canine osteoarthritis: effectiveness of Qs Vet Magnetotherapy
This issue of Energy for Health brings together articles on several topics concerning the application of laser therapy both in the field of human medicine and in the field of veterinary medicine. In the first category, the published manuscripts concentrate on HILT®. The first article, a review, analyses the action mechanisms and the clinical evidence underlying Hilterapia®, whilst the second one describes the experience of a group of doctors when using the HILT® pulse combined with extracorporeal shock wave therapy for treating plantar fasciitis. The other two articles present successful cases when using lasers belonging to the MLS® family for treating canine osteoarthritis and avulsion of the brachial plexus.
Biological effects and clinical cases: evidence with Hilterapia®
Plantar fasciitis: new treatment for chronic pain
Laser puncture in the elderly dog: 3 clinical cases
Brachial plexus injury: vet treatment with MLS®
Energy for Health presents in this issue four case reports dedicated to the application of MLS® therapy in various areas of human and veterinary medicine. As regards veterinary medicine, the first article reports interesting evidence on the effectiveness of MLS® therapy in the management of a necrotic lesion, presumably resulting from a spider bite, affecting the forelimb of an adult dog. In the second case report, which describes a study carried out on a python, MLS® therapy is applied to treat a severe form of stomatitis and the positive effects obtained are reported in terms of inflammation reduction. In the first article of human medicine, the effectiveness of MLS® therapy in promoting the complete healing of a diabetic foot ulcer is demonstrated. Finally, a case report is reported whose results support the potential use of MLS® therapy as a therapeutic resource in the management of COVID-19 patients.
COVID-19: MLS® Laser Therapy as a therapeutic resource
Diabetic foot: MLS® Laser Therapy promotes the complete healing of an ulcer
Veterinary medicine: MLS® Laser Therapy to treat a severe form of stomatitis
Veterinary medicine: MLS® Laser Therapy in the management of a necrotic lesion
This new issue of Energy for Health is completely dedicated to laser therapy. The first article is a clinical study that demonstrates the efficacy of MLS® Laser Therapy, combined with the use of a bite splint, in reducing the painful symptoms associated with temporomandibular disorders. The second study describes a "case report" where interesting evidence has been obtained in regards of the positive effects of Hilterapia® in the management of pain in a young patient affected by Tietze syndrome. The third article, a report describing the clinical experience of two independent Italian physiotherapy centers with the use of HIRO TT, shows the efficacy of this therapeutic strategy in the treatment of multiple conditions that characterize musculoskeletal pathologies. Lastly, a study carried out by veterinary doctors presents results supporting the use of laser acupuncture as a valid therapeutic resource for the treatment of various behavioral disorders in the dog.
Temporomandibular disorders: Evaluation of the effects of MLS® combined with Ora-GuardTM
Tietze syndrome: Pain management with Hilterapia®
Musculoskeletal pathologies: Clinical application of HIRO TT
Veterinary medicine: MLS® Laserpuncture for dog behavioural problems
In this nineteenth issue, Energy for Health presents insight concerning both laser- and magnetotherapy. The first paper reports the results of a preliminary study on the effects of the MiS laser in the management of neuropathic pain. The second paper describes a retrospective study where the efficacy of MLS® therapy in the treatment of multiple musculoskeletal conditions is highlighted in terms of pain reduction and patient’s satisfaction. In another paper concerning an in vitro study performed on a model of nerve cells, the safety and effectiveness of exposure to magnetotherapy are evaluated. Finally, it is presented a “case report” of veterinary medicine where a positive effect of MLS® therapy applied in the treatment of necrotizing fasciitis is evidenced.
Neuropathic pain: preliminary clinical case records on MiS laser effects
Musculoskeletal pain: clinical effects of MLS®
In vitro studies: effectiveness and safety of exposure to magnetotherapy
Veterinary medicine: use of MLS® for necrotising fasciitis
The contents of issue number 18 of Energy for Health offer insights into the use of MLS® therapy in various areas of human and veterinary medicine. In particular, as regards veterinary medicine, the authors of the first study (Cabassi et al.) assessed the efficacy of laser therapy for the treatment of canine pyoderma, a pathological condition in which a bacterial infection forms at skin level.
The second work presented is a retrospective dentistry study (Doan & Duong) concerning the clinical effects of MLS® therapy in dental implant operations in postmenopausal women. It highlights the efficacy of MLS® therapy in pain management and the fewer complications recorded in laser-treated implants.
The third work (Friederichs) analyses the use of laser therapy in the treatment of inattentive symptomatology in patients with learning and attention deficit, demonstrating that an improvement in symptoms is recorded after 10 laser treatments.
Finally, the last article presented (Guzman et al.) evaluates the use of MLS® therapy for managing low back pain.
Canine pyoderma: efficacy of MLS® Laser Therapy
Dentistry: clinical effects of MLS® in dental implant operations
Central auditory processing disorder (CAPD): MLS® in the treatment of inattentive symptoms
Low-back pain: use of MLS® in pain management
The contents of the seventeenth issue of Energy for Health, the scientific journal of ASAcampus, concern insights both on laser therapy and on magnetotherapy. The first article describes a "case report" which demonstrates the efficacy of MLS® therapy in reducing the pain symptoms associated with cervical radiculopathy. The second study, conducted by dentists, reports a series of cases where MLS® therapy is associated to the use of a dental bite in the treatment of craniofacial pain and temporomandibular joint disorders. The third article describes the results obtained in two centres which treated a total of 100 patients with HIRO TT, a new therapeutic strategy that combines the pulsed Nd: YAG laser source with a refrigerant system which lowers the temperature of the skin and underlying tissues (SmartCooler). Lastly, there is a basic study aimed at understanding the cellular and molecular mechanisms underlying the biological effects of electromagnetic fields.
Cervical radiculopathy: a Case Report treated with MLS® Laser Therapy
Dentistry: MLS® therapy and dental bite in temporomandibular disorders
HIRO TT: a new therapeutic strategy
Magnetotherapy: in vitro trial in a fibroblast model
Four articles dedicated to MLS® Laser Therapy: the first, conducted by dentists, demonstrates its effectiveness in treating disorders in the maxillofacial and oral region by reporting two "case reports", the second study concerns the benefits of MLS® therapy in treating patients with tendinitis. The third discusses the hypothesis of stimulation by means of MLS® Laser Therapy in patients with symptoms caused by hearing impairment; the last one talks about how MLS® represents a valuable aid in managing the painful symptoms associated with degenerative diseases of dog joints.
Dentistry: MLS® and disorders in the maxillofacial and oral region
Tendinopathies: benefits of MLS® Laser Therapy
Hearing: MLS® Laser Therapy and auditory stimulation
Veterinary medicine: MLS® and pain management in degenerative joint diseases
Four articles dedicated to MLS® therapy. The first, conducted by dentists, demonstrates the efficacy of MLS® therapy in treating the painful condition resulting from tooth extraction. The second study, which concerns the treatment of patients suffering from musculoskeletal disorders, compares the effects of MLS® laser therapy with those of a "single wavelength" NIR source. The third article describes a "case study" which reports interesting evidence on the efficacy of MLS® therapy in trigeminal neuralgia pain management. Finally, a study on the safety and clinical efficacy of laser acupuncture performed with MLS® laser in spinal pain management is presented.
Dentistry: MLS® in post dental extraction
Musculoskeletal disorders: comparison between MLS® and a pulsed NIR laser
Craniofacial pain: a clinical case of neuropathic pain treated with MLS®
Laser puncture: MLS® and spinal pain
Fill out the form, ASA’s Research Division is at your disposal.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.